The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
Open accessAbstract
BACKGROUND & AIMS: Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (CDI). However, transferring undefined living bacteria entails uncontrollable risks for infectious and metabolic or malignant diseases, particularly in immunocompromised patients. We investigated whether sterile fecal filtrates (containing bacterial debris, proteins, antimicrobial compounds, metabolic products, and oligonucleotides/DNA), rather than intact microorganisms, are effective in patients with CDI. METHODS: We performed a clinical case series to investigate the effects of fecal filtrate transfer (FFT) in 5 patients with symptomatic chronic-relapsing CDI at the Department of Internal Medicine I at the University Hospital Schleswig-Holstein (Kiel, Germany). Patients were followed up for at least 6 months and for up to 33 months. Stool was collected from 5 donors selected by the patients, and fully characterized according to FMT standards. Stool was sterile-filtered to remove small particles and bacteria; the filtrate was transferred to patients in a single administration via nasojejunal tube. Fecal samples were collected from patients before and at 1 week and 6 weeks after FFT. Microbiome, virome, and proteome profiles of donors and patients were compared. RESULTS: In all 5 patients, FFT restored normal stool habits and eliminated symptoms of CDI for a minimum period of 6 months. Proteome analyses of selected FFT filtrates showed no obvious protein candidates associated with therapeutic efficacy. 16S ribosomal RNA gene sequencing detected diverse bacterial DNA signatures in the filtrates. Analysis of virus-like particles from a filtrate found to reduce symptoms of CDI showed a complex signature of bacteriophages. Bacterial phylogeny and virome profile analyses of fecal samples from recipients indicated longitudinal changes in microbial and viral community structures after FFT. CONCLUSIONS: A preliminary investigation of 5 patients with CDI shows that transfer of sterile filtrates from donor stool (FFT), rather than fecal microbiota, can be sufficient to restore normal stool habits and eliminate symptoms. This finding indicates that bacterial components, metabolites, or bacteriophages mediate many of the effects of FMT, and that FFT might be an alternative approach, particularly for immunocompromised patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following successful treatment of C. difficile infection by FFT transplantation, the gut microbiota of a patient with loss of renal function resembled that of the faecal donor with remarkable elimination of Proteobacteria, which had dominated before FFT226.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [226]
In the citing paper
“The risk of secondary infection may be lower with FFT than with FMT, as FFT does not involve the transfer of live bacteria226.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
PAST: PALEONTOLOGICAL STATISTICAL SOFTWARE PACKAGE FOR EDUCATION AND DATA ANALYSIS
Hammer, Ø., Harper, D. A. T., & Ryan, P. D. (2001) · Palaeontologia Electronica · Cited by 17,871
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Fadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698
Self-citationAssembling Single-Cell Genomes and Mini-Metagenomes From Chimeric MDA Products
Nurk, S., Bankevich, A., Antipov, D., Gurevich, A. A., Korobeynikov, A., Lapidus, A. L., Prjibelski, A. D., Pyshkin, A., Sirotkin, A., Sirotkin, Y., et al. (2013) · Journal of Computational Biology · doi:10.1089/cmb.2013.0084 · Cited by 1,352
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
Research works printed but not linked: 1
- Reyes, 2010, Viruses in the faecal microbiota of monozygotic twins and their mothers, Nature, 466, 334, 10.1038/nature09199 · DOI
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
The resilience of the intestinal microbiota influences health and disease
Sommer, F., Anderson, J. M., Bharti, R., Raes, J., & Rosenstiel, P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.58 · Cited by 1,058
Self-citationKhan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771
Bacteriophages of the Human Gut: The “Known Unknown” of the Microbiome
Shkoporov, A. N., & Hill, C. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.017 · Cited by 783
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Human Gut Microbiome: Function Matters
Heintz‐Buschart, A., & Wilmes, P. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.11.002 · Cited by 779
Current challenges and best-practice protocols for microbiome analysis
Bharti, R., & Grimm, D. G. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz155 · Cited by 592
Self-citationParamsothy, S., Nielsen, S. J., Kamm, M. A., Deshpande, N., Faith, J. J., Clemente, J. C., Paramsothy, R., Walsh, A. J., van den Bogaerde, J., Samuel, D., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.12.001 · Cited by 523
Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction
Bouter, K. E. C., van Raalte, D. H., Groen, A. K., & Nieuwdorp, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.048 · Cited by 443
Role of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418
The Super-Donor Phenomenon in Fecal Microbiota Transplantation
Wilson, B. C., Vatanen, T., Cutfield, W. S., & O'Sullivan, J. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00002 · Cited by 442
The Healthy Microbiome—What Is the Definition of a Healthy Gut Microbiome?
Shanahan, F., Ghosh, T. S., & O’Toole, P. W. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.057 · Cited by 383
Fecal microbiota transplantation: current challenges and future landscapes
Yadegar, A., Bar‐Yoseph, H., Monaghan, T. M., Pakpour, S., Severino, A., Kuijper, E. J., Smits, W. K., Terveer, E. M., Neupane, S., Nabavi-Rad, A., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-22 · Cited by 397
The role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 370
Zuo, T., Wong, S. H., Lam, K., Lui, R. N.-S., Cheung, K., Tang, W., Ching, J. Y. L., Chan, P. K. S., Chan, M. C. W., Wu, J. C., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-313952 · Cited by 376
Craven, L. J., Rahman, A., Parvathy, S. N., Beaton, M. D., Silverman, J. D., Qumosani, K. M., HRAMIAK, I. M., Hegele, R., JOY, T. R., Meddings, J. B., et al. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000661 · Cited by 354
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Chong, P. P., Chin, V. K., Looi, C. Y., Wong, W. F., Madhavan, P., & Yong, P. V. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01136 · Cited by 353
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31266-8 · Cited by 358
Gut microbiota injury in allogeneic haematopoietic stem cell transplantation
Shono, Y., & van den Brink, M. R. M. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2018.10 · Cited by 320
The microbiome in threatened species conservation
West, A. G., Waite, D. W., Deines, P., Bourne, D. G., Digby, A., McKenzie, V. J., & Taylor, M. W. (2018) · Biological Conservation · doi:10.1016/j.biocon.2018.11.016 · Cited by 324
Mining the microbiota for microbial and metabolite-based immunotherapies
Skelly, A. N., Sato, Y., Kearney, S., & Honda, K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0144-5 · Cited by 306
The gut virome: A new microbiome component in health and disease
Cao, Z., Sugimura, N., Burgermeister, E., Ebert, M. P. A., Zuo, T., & Lan, P. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104113 · Cited by 303
Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris
O’Neill, A. M., & Gallo, R. L. (2018) · Microbiome · doi:10.1186/s40168-018-0558-5 · Cited by 334
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
Xavier, J. B., Young, V. B., Skufca, J. D., Ginty, F., Testerman, T. L., Pearson, A. T., Macklin, P., Mitchell, A., Shmulevich, I., Xie, L., et al. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.004 · Cited by 272
Mullish, B. H., McDonald, J. A. K., Pechlivanis, A., Allegretti, J. R., Kao, D., Barker, G. F., Kapila, D., Petrof, E. O., Joyce, S. A., Gahan, C. G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317842 · Cited by 268
Costello, S. P., Soo, W. T., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14173 · Cited by 260
Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model
Rasmussen, T. S., Mentzel, C. M. J., Kot, W., Castro-Mejía, J. L., Zuffa, S., Swann, J. R., Hansen, L. H., Vogensen, F. K., Hansen, A. K., & Nielsen, D. S. (2020) · Gut · doi:10.1136/gutjnl-2019-320005 · Cited by 260
The Human Gut Phage Community and Its Implications for Health and Disease
Manrique, P., Dills, M., & Young, M. (2017) · Viruses · doi:10.3390/v9060141 · Cited by 262
Review article: the human intestinal virome in health and disease
Carding, S. R., Davis, N., & Hoyles, L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14280 · Cited by 251
Microbiome-based interventions to modulate gut ecology and the immune system
Hitch, T. C. A., Hall, L. J., Walsh, S. K., Leventhal, G. E., Slack, E. M. C., de Wouters, T., Walter, J., & Clavel, T. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00564-1 · Cited by 268
The Gut Microbiota: Emerging Evidence in Autoimmune Diseases
Zhang, X., Chen, B.-D., Zhao, L., & Li, H. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.04.001 · Cited by 258
Drivers and determinants of strain dynamics following fecal microbiota transplantation
Schmidt, T. S. B., Li, S. S., Maistrenko, O. M., Akanni, W., Coelho, L. P., Dolai, S., Fullam, A., Glazek, A. M., Hercog, R., Herrema, H., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01913-0 · Cited by 233
New insights into intestinal phages
Sausset, R., Petit, M., Gaboriau‐Routhiau, V., & Paepe, M. D. (2020) · Mucosal Immunology · doi:10.1038/s41385-019-0250-5 · Cited by 238
Gut Microbiota and Diarrhea: An Updated Review
Li, Y., Xia, S., Jiang, X., Feng, C., Gong, S., Ma, J., Fang, Z., Yin, J., & Yin, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625210 · Cited by 219
A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
Rodiño‐Janeiro, B. K., Vicario, M., Alonso, C., Pascua-García, R., & Santos, J. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0673-5 · Cited by 223
Elinav, E., Garrett, W. S., Trinchieri, G., & Wargo, J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0155-3 · Cited by 215
Gut Bacteriophage: Current Understanding and Challenges
Sutton, T., & Hill, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00784 · Cited by 199
Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future?
Hanssen, N. M. J., de Vos, W. M., & Nieuwdorp, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.005 · Cited by 202
Seekatz, A. M., Theriot, C. M., Rao, K. K., Chang, Y., Freeman, A. E., Kao, J. Y., & Young, V. B. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2018.04.001 · Cited by 197
McDonald, J. A. K., Mullish, B. H., Pechlivanis, A., Liu, Z., Brignardello, J., Kao, D. H., Holmes, E. C., Li, J. V., Clarke, T. B., Thursz, M. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.014 · Cited by 200
Ma, L., Shen, Q., Lyu, W., Lv, L., Wang, W., Yu, M., Yang, H., Tao, S., & Xiao, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01368-22 · Cited by 196
Schoultz, I., & Keita, Å. V. (2019) · Cells · doi:10.3390/cells8020193 · Cited by 193
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies
Bokoliya, S. C., Dorsett, Y., Panier, H. A., & Zhou, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.711055 · Cited by 194
Mutualistic interplay between bacteriophages and bacteria in the human gut
Shkoporov, A. N., Turkington, C. J. R., & Hill, C. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00755-4 · Cited by 200
Metagenomics: An Effective Approach for Exploring Microbial Diversity and Functions
Nam, N. N., Do, H. D. K., Trinh, K. T. L., & Lee, N. Y. (2023) · Foods · doi:10.3390/foods12112140 · Cited by 213
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases
Oka, A., & Sartor, R. B. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06090-z · Cited by 188
Review article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D’Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Marcelino, V. R., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 204
The gut virome: the ‘missing link’ between gut bacteria and host immunity?
Mukhopadhya, I., Segal, J. P., Carding, S. R., Hart, A. L., & Hold, G. L. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819836620 · Cited by 180
Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management
Mcilroy, J. R., Ianiro, G., Mukhopadhya, I., Hansen, R., & Hold, G. L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14384 · Cited by 178
Viral communities of the human gut: metagenomic analysis of composition and dynamics
Aggarwala, V., Liang, G., & Bushman, F. D. (2017) · Mobile DNA · doi:10.1186/s13100-017-0095-y · Cited by 185
The Gut Microbiota Facilitates Drifts in the Genetic Diversity and Infectivity of Bacterial Viruses
Sordi, L. D., Khanna, V., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.010 · Cited by 169
The Battle Within: Interactions of Bacteriophages and Bacteria in the Gastrointestinal Tract
Sordi, L. D., Lourenço, M., & Debarbieux, L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.018 · Cited by 168
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Bajaj, J. S., & Khoruts, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.017 · Cited by 172
Fecal microbiota transplantation beyond Clostridioides difficile infections
Wortelboer, K., Nieuwdorp, M., & Herrema, H. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.066 · Cited by 163
Vemuri, R., Shankar, E. M., Chieppa, M., Eri, R., & Kavanagh, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040483 · Cited by 162
Optimization of fecal sample processing for microbiome study — The journey from bathroom to bench
Wu, W., Chen, C., Panyod, S., Chen, R.-A., Wu, M., Sheen, L., & Chang, S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.02.005 · Cited by 167
Draper, L. A., Ryan, F. J., Smith, M. K., Jalanka, J., Mattila, E., Arkkila, P., Ross, R. P., Satokari, R. M., & Hill, C. (2018) · Microbiome · doi:10.1186/s40168-018-0598-x · Cited by 165
Bella, S. D., Sanson, G., Monticelli, J., Zerbato, V., Principe, L., Giuffrè, M., Pipitone, G., & Luzzati, R. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00135-23 · Cited by 202
Probiotics for prevention of Clostridium difficile infection
Mills, J., Rao, K. K., & Young, V. B. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000410 · Cited by 178
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder
Bastiaanssen, T. F. S., Cussotto, S., Claesson, M. J., Clarke, G., Dinan, T. G., & Cryan, J. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000243 · Cited by 159
Fecal filtrate transplantation protects against necrotizing enterocolitis
Brunse, A., Deng, L., Pan, X., Yan, H., Castro-Mejía, J. L., Kot, W., Nguyen, D. N., Secher, J. B., Nielsen, D. S., & Thymann, T. (2021) · The ISME Journal · doi:10.1038/s41396-021-01107-5 · Cited by 158
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
Khoruts, A., Staley, C., & Sadowsky, M. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0350-4 · Cited by 155
Recipient factors in faecal microbiota transplantation: one stool does not fit all
Danne, C., Rolhion, N., & Sokol, H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00441-5 · Cited by 154
Lee, P. C., Yacyshyn, B., & Yacyshyn, M. B. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13561 · Cited by 159
Microbiome therapeutics: exploring the present scenario and challenges
Yadav, M., & Chauhan, N. S. (2021) · Gastroenterology report · doi:10.1093/gastro/goab046 · Cited by 164
Shogbesan, O., Poudel, D. R., Victor, S., Jehangir, A., Fadahunsi, O., Shogbesan, G., & Donato, A. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/1394379 · Cited by 149
Microbiota and mucosal defense in IBD: an update
Stange, E. F., & Schroeder, B. O. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1671822 · Cited by 154
Update of treatment algorithms for Clostridium difficile infection
Ooijevaar, R. E., van Beurden, Y. H., Terveer, E. M., Goorhuis, A., Bauer, M. P., Keller, J. J., Mulder, C. J. J., & Kuijper, E. J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.022 · Cited by 146
Studying the gut virome in the metagenomic era: challenges and perspectives
Garmaeva, S., Sinha, T., Kurilshikov, A., Fu, J., Wijmenga, C., & Zhernakova, A. (2019) · BMC Biology · doi:10.1186/s12915-019-0704-y · Cited by 141
Doering, T., Wall, M., Putchim, L., Rattanawongwan, T., Schroeder, R., Hentschel, U., & Roik, A. (2021) · Microbiome · doi:10.1186/s40168-021-01053-6 · Cited by 142
Expanding known viral diversity in the healthy infant gut
Shah, S. A., Deng, L., Thorsen, J., Pedersen, A. G., Dion, M. B., Castro-Mejía, J. L., Silins, R., Romme, F. O., Sausset, R., Jessen, L. E., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01345-7 · Cited by 148
Role of the microbiota in response to and recovery from cancer therapy
Blake, S. J., Wolf, Y., Boursi, B., & Lynn, D. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00951-0 · Cited by 151
Patey, O., McCallin, S. E., Mazure, H., Liddle, M., Smithyman, A. M., & Dublanchet, A. (2018) · Viruses · doi:10.3390/v11010018 · Cited by 140
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
Ding, X. L., Li, Q., Li, P., Zhang, T., Cui, B., Ji, G., Lü, X., & Zhang, F. (2019) · Drug Safety · doi:10.1007/s40264-019-00809-2 · Cited by 139
Inflammaging as a target for healthy ageing
Dugan, B., Conway, J., & Duggal, N. A. (2023) · Age and Ageing · doi:10.1093/ageing/afac328 · Cited by 154
The path towards microbiome-based metabolite treatment
Suez, J., & Elinav, E. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.75 · Cited by 134
Pathogenicity and virulence of Clostridioides difficile
Buddle, J. E., & Fagan, R. P. (2022) · Virulence · doi:10.1080/21505594.2022.2150452 · Cited by 147
Bacteriophage-mediated manipulation of the gut microbiome – promises and presents limitations
Rasmussen, T. S., Koefoed, A. K., Jakobsen, R. R., Deng, L., Castro-Mejía, J. L., Brunse, A., Neve, H., Vogensen, F. K., & Nielsen, D. S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa020 · Cited by 123
Davidovics, Z. H., Michail, S. K., Nicholson, M. R., Kociolek, L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A., Shamir, R., Szajewska, H., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002205 · Cited by 132
Mukherjee, S., Joardar, N., Sengupta, S., & Babu, S. P. S. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.010 · Cited by 129
A Wake-Up Call: We Need Phage Therapy Now
Moelling, K., Broecker, F., & Willy, C. (2018) · Viruses · doi:10.3390/v10120688 · Cited by 126
Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases
Iliev, I. D., & Cadwell, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.100 · Cited by 128
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
Bibbò, S., Settanni, C. R., Porcari, S., Bocchino, E., Ianiro, G., Cammarota, G., & Gasbarrini, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061757 · Cited by 132
Bacteriophages in the gastrointestinal tract and their implications
Łusiak-Szelachowska, M., Weber‐Dąbrowska, B., Jończyk‐Matysiak, E., Wojciechowska, R., & Górski, A. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0196-7 · Cited by 127
Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs
Feng, W., Liu, J., Ao, H., Yue, S., & Peng, C. Y. (2020) · Theranostics · doi:10.7150/thno.47289 · Cited by 131
Ng, S. C., Kamm, M. A., Yeoh, Y. K., Chan, P. K. S., Zuo, T., Tang, W., Sood, A., Andoh, A., Ohmiya, N., Zhou, Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319407 · Cited by 121
The Intestinal Virome and Immunity
Neil, J. A., & Cadwell, K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800631 · Cited by 117
Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes
Lam, K. N., Alexander, M., & Turnbaugh, P. J. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.06.011 · Cited by 119
Immune-Microbiota Interplay and Colonization Resistance in Infection
Leshem, A., Liwinski, T., & Elinav, E. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.001 · Cited by 117
Adiliaghdam, F., Amatullah, H., Digumarthi, S., Saunders, T. L., Rahman, R., Wong, L. P., Sadreyev, R. I., Droit, L., Paquette, J., Goyette, P., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abn6660 · Cited by 109
Delivery routes for faecal microbiota transplants: Available, anticipated and aspired
Gulati, M., Singh, S. K., Corrie, L., Kaur, I. P., & Chandwani, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104954 · Cited by 116
Clostridioides difficile: diagnosis and treatments
Guery, B. P., Galpérine, T., & Barbut, F. (2019) · BMJ · doi:10.1136/bmj.l4609 · Cited by 117
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Zhang, Y., Xiao, Z., Yu, X., Novák, P., Gui, Q., & Yin, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1120168 · Cited by 112
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Xiu, W., Peng, J., Cai, P., Xia, Y., Yi, C., Shang, A., Akanyibah, F. A., & Mao, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117302 · Cited by 117
Wilson, B. C., Vatanen, T., Jayasinghe, T. N., Leong, K. S. W., Derraik, J. G. B., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01060-7 · Cited by 105
Baktash, A., Terveer, E. M., Zwittink, R. D., Hornung, B., Corver, J., Kuijper, E. J., & Smits, W. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01242 · Cited by 112
Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
Lopetuso, L. R., Giorgio, M. E., Saviano, A., Scaldaferri, F., Gasbarrini, A., & Cammarota, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010183 · Cited by 110
Liu, R., Kang, J. D., Sartor, R. B., Sikaroodi, M., Fagan, A., Gavis, E. A., Zhou, H., Hylemon, P. B., Herzog, J., Li, X., et al. (2019) · Hepatology · doi:10.1002/hep.30827 · Cited by 107
Singh, R., de Groot, P. F., Geerlings, S. E., Hodiamont, C. J., Belzer, C., ten Berge, I. J. M., de Vos, W. M., Bemelman, F. J., & Nieuwdorp, M. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3293-x · Cited by 101
Metadata
- Authors
- Ott, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., Rosenstiel, P., & Schreiber, S.
- Affiliations
- University Hospital Schleswig-Holstein (DE)
- Conaris (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- San Diego State University (US)
- Corresponding author
- Schreiber, Stefan
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 152
- Issue
- 4
- Pages
- 799-811.e7
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2550586225
- Cited by
- 695
- References
- 54
- Citations by year
- 2026: 37 · 2025: 64 · 2024: 83 · 2023: 73 · 2022: 85 · 2021: 96 · 2020: 65 · 2019: 82 · 2018: 69 · 2017: 38
- FWCI
- 58.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gastroenterology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (CRC 1182)
- Exzellenzclusters Entzündungsforschung
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, recurrent Clostridium difficile infection, sterile filtration, bacteriophages, virome, microbiome, immunocompromised patients, bacterial community structure
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Aged, Enterocolitis, Pseudomembranous, Female, Filtration, Humans, Male, Middle Aged, Recurrence, Sterilization, Clostridioides difficile, Proteome, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
